Barclays’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,737
| Closed | -$24K | – | 4260 |
|
|
2021
Q1 | $24K | Sell |
7,737
-47,320
| -86% | -$147K | ﹤0.01% | 3633 |
|
|
2020
Q4 | $144K | Sell |
55,057
-545
| -1% | -$1.43K | ﹤0.01% | 2852 |
|
|
2020
Q3 | $160K | Sell |
55,602
-38,971
| -41% | -$112K | ﹤0.01% | 2842 |
|
|
2020
Q2 | $324K | Sell |
94,573
-227
| -0.2% | -$778 | ﹤0.01% | 2563 |
|
|
2020
Q1 | $188K | Sell |
94,800
-3,356
| -3% | -$6.66K | ﹤0.01% | 2569 |
|
|
2019
Q4 | $393K | Buy |
98,156
+2,502
| +3% | +$10K | ﹤0.01% | 2823 |
|
|
2019
Q3 | $305K | Buy |
95,654
+49,023
| +105% | +$156K | ﹤0.01% | 2868 |
|
|
2019
Q2 | $182K | Buy |
46,631
+2,135
| +5% | +$8.33K | ﹤0.01% | 3257 |
|
|
2019
Q1 | $1.08M | Buy |
44,496
+19,696
| +79% | +$479K | ﹤0.01% | 2091 |
|
|
2018
Q4 | $499K | Buy |
+24,800
| New | +$499K | ﹤0.01% | 2266 |
|
|
2013
Q3 | – | Sell |
-79
| Closed | -$10K | – | 4328 |
|
|
2013
Q2 | $10K | Buy |
+79
| New | +$10K | ﹤0.01% | 3902 |
|